Aziyo Biologics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aziyo Biologics's balance sheet done over the years? Its assets were worth $68,841,000 last year, which is more than in the previous period. 107% of Aziyo Biologics’s total assets is currently financed by debt. Its liabilities reached the amount of $73,874,000, which means an increase by 38% compared compared to last year.

Debt to Assets

Aziyo Biologics, Inc. (NASDAQ:AZYO): Debt to assets
2018 47741000 91.14M 190.92%
2019 44772000 99.88M 223.09%
2020 82810000 61.97M 74.84%
2021 67170000 53.64M 79.87%
2022 68841000 73.87M 107.31%

AZYO Balance Sheet (2018 – 2022)

2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
16.98M30.42M39.53M2.48M2.36M
Short term investments
00000
Net receivables
20.64M5.99M7.16M7.22M7.2M
Inventory
10.05M9.55M10.11M7.19M7.45M
Other current assets
3.01M1.45M2.89M1.43M1.06M
Total current assets
50.69M47.42M59.70M18.44M18.13M
Non-current assets:
Property, Plant and Equipment
3.07M1.2M1.16M988K870K
Goodwill
00000
Intangible assets
15.06M18.46M21.86M25.26M28.66M
Long term investments
00000
Other non-current assets
076K76K76K76K
Total non-current assets
18.14M19.74M23.10M26.32M29.60M
Total assets
68.84M67.17M82.81M44.77M47.74M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
05K533K650K648K
Short term debt
9.67M15.57M15.57M5.91M3.00M
Total current liabilities
42.61M26.00M26.77M18.27M13.34M
Non-current liabilities:
Long term debt
25.21M10.41M17.81M19.61M16.45M
Deferred tax
00000
Other non-current liabilities
6.04M16.54M16.63M16.59M18.05M
Total non-current liabilities
31.25M27.64M35.2M81.60M77.80M
Total liabilities
73.87M53.64M61.97M99.88M91.14M
Data sourceData sourceData source